Format

Send to

Choose Destination
Vaccine. 2004 Feb 25;22(8):1007-15.

Trypanosome microtubule-associated protein p15 as a vaccine for the prevention of African sleeping sickness.

Author information

1
Department of Nutrition, University of California, One Shields Avenue, Meyer Hall, Room 3135, Davis, CA 95616, USA. rrasooly@whnrc.usda.gov

Abstract

Trypanosomes cause African sleeping sickness, affecting millions of humans and animals. We tested trypanosome microtubule-associate protein (MAP p15) as a vaccine in mice, and show that p15 (native or recombinant) generated up to 100% protection from an otherwise lethal challenge of a heterologous strain of Trypanosoma brucei. We also tested the adenovirus as a vaccine delivery system and show that both adenoviral vector containing p15 gene or control adenovirus containing lacZ gene generated a protective response and exhibited strong CD8+ T-cell proliferation. These results suggest that the p15 protein itself is an effective vaccine and that the adenovirus may be used to mount a non-specific cellular immune response.

PMID:
15161078
DOI:
10.1016/j.vaccine.2003.08.041
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center